CHRS Coherus Oncology, Inc.
$1.07▲ +5.94%
Healthcare
Other
After hours
$1.07▲ +0.00%
Oct 27, 4:28 PM ET
Volume 604.1K
Avg Volume (10D) 1.15M
Key Metrics & Fundamentals
Market Cap
$165.32M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.94 - 2.62
% vs 50 MA
-12.32%
% vs 200 MA
-30.56%
RSI-14
47.1
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.67
Free Cash Flow
-$62.09M
Gross Rev
$14.31M
Gross Profit
$10.07M
EBITDA
-$30.16M
COGS
$4.24M
Operating Exp
$42.40M
Operating Income
-$32.33M
EBIT
-$32.33M
Pretax Income
-$33.35M
Net Income
-$20.63M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
Coherus to Participate in Upcoming Investor Conferences
GlobeNewswire · Oct 27, 2026 9:30 AM ET
Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
GlobeNewswire · Oct 26, 2026 9:30 AM ET
Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026
GlobeNewswire · Oct 14, 2026 4:30 PM ET
Coherus Oncology Starts Process to Sell Remaining Biosimilar Assets
MT Newswires · Sep 23, 2026 10:08 AM ET
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
GlobeNewswire · Sep 23, 2026 9:30 AM ET
Coherus to Participate in Upcoming Investor Conferences
GlobeNewswire · Aug 31, 2026 9:30 AM ET
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
GlobeNewswire · Aug 17, 2026 5:33 PM ET
Coherus Oncology (CHRS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 8:31 PM ET
Coherus Oncology, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 6, 2026 8:30 AM ET
Coherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: LOQTORZI Growth and Pipeline ...
GuruFocus.com · Aug 6, 2026 1:03 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CHRS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.